These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3498658)

  • 61. Tumor necrosis factor-alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures.
    Centrella M; McCarthy TL; Canalis E
    Endocrinology; 1988 Sep; 123(3):1442-8. PubMed ID: 3402390
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Parathyroid hormone-related protein modulates the effect of transforming growth factor-beta on deoxyribonucleic acid and collagen synthesis in fetal rat bone cells.
    Centrella M; Canalis E; McCarthy TL; Stewart AF; Orloff JJ; Insogna KL
    Endocrinology; 1989 Jul; 125(1):199-208. PubMed ID: 2737143
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
    Kanno H; Shinonaga M; Kuwabara T; Umeda M
    No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of a new bone-inducing biomaterial on mesenchymal cells in vitro.
    Joos UE; Fehrenbach E; Hogh-Janovsky K; Wimmer FM; Schneider EM; Schmidt KH
    Artif Organs; 1992 Aug; 16(4):354-60. PubMed ID: 10078274
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration.
    Kan M; Huang JS; Mansson PE; Yasumitsu H; Carr B; McKeehan WL
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7432-6. PubMed ID: 2477840
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
    Reddy CC; Wells A; Lauffenburger DA
    J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
    [TBL] [Abstract][Full Text] [Related]  

  • 67. c-fos protooncogene is involved in the mitogenic effect of transforming growth factor-beta in osteoblastic cells.
    Machwate M; Jullienne A; Moukhtar M; Lomri A; Marie PJ
    Mol Endocrinol; 1995 Feb; 9(2):187-98. PubMed ID: 7776969
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Transforming growth factor beta and fibroblast growth factor have opposite effects on the proliferation of endothelial cells].
    Fràter-Schröder M; Müller G; Birchmeier W; Böhlen P
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1160-2. PubMed ID: 3464090
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transforming and nontransforming growth factors are present in medium conditioned by fetal rat calvariae.
    Centrella M; Canalis E
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7335-9. PubMed ID: 2997787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects on glycosaminoglycan synthesis in cultured human mesothelioma cells of transforming, epidermal, and fibroblast growth factors and their combinations with platelet-derived growth factor.
    Tzanakakis GN; Karamanos NK; Hjerpe A
    Exp Cell Res; 1995 Sep; 220(1):130-7. PubMed ID: 7664829
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beta 2-microglobulin is not a bone cell mitogen.
    Jennings JC; Mohan S; Baylink DJ
    Endocrinology; 1989 Jul; 125(1):404-9. PubMed ID: 2661210
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bi-functional action of transforming growth factor-beta on DNA synthesis in early passage human fetal fibroblasts.
    Hill DJ; Strain AJ; Elstow SF; Swenne I; Milner RD
    J Cell Physiol; 1986 Aug; 128(2):322-8. PubMed ID: 3488321
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential chemotactic responses of different populations of fetal rat calvaria cells to platelet-derived growth factor and transforming growth factor beta.
    Hughes FJ; Aubin JE; Heersche JN
    Bone Miner; 1992 Oct; 19(1):63-74. PubMed ID: 1422306
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fibroblasts from wounds of different stages of repair vary in their ability to contract a collagen gel in response to growth factors.
    Finesmith TH; Broadley KN; Davidson JM
    J Cell Physiol; 1990 Jul; 144(1):99-107. PubMed ID: 2365747
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of transforming growth factors on bone cells.
    Centrella M; McCarthy TL; Canalis E
    Connect Tissue Res; 1989; 20(1-4):267-75. PubMed ID: 2692955
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Skeletal tissue and transforming growth factor beta.
    Centrella M; McCarthy TL; Canalis E
    FASEB J; 1988 Dec; 2(15):3066-73. PubMed ID: 2903838
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation.
    Rosenthal A; Lindquist PB; Bringman TS; Goeddel DV; Derynck R
    Cell; 1986 Jul; 46(2):301-9. PubMed ID: 3459590
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of fibroblast growth factor and the extracellular matrix in the control of proliferation and differentiation of corneal endothelial cells.
    Gospodarowicz D; Vlodavsky I; Savion N
    Vision Res; 1981; 21(1):87-103. PubMed ID: 6455845
    [No Abstract]   [Full Text] [Related]  

  • 79. Human uterus-derived growth substances for rat bone cells and fibroblasts.
    Koutsilieris M
    Am J Obstet Gynecol; 1989 Nov; 161(5):1313-7. PubMed ID: 2589457
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stimulation of lysosomal enzyme secretion by growth factors.
    Warren L
    Exp Cell Res; 1990 Sep; 190(1):133-6. PubMed ID: 2387325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.